Limited-Time September Offer: Try 7 Days for Free

Integra Lifesciences (IART) Stock Price

$15.06 0%

Sign up
to add to portfolio

AI Score

  • Alternative

    5
  • Fundamental

    2
  • Technical

    4

Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.

Sign up to get access to more historical data and insights on Integra Lifesciences, AI stock picks, stock alerts and much more.

Sign up

IART AI Stock Analysis

AI stock analysis for IART is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Integra Lifesciences (IART) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Integra Lifesciences (IART) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Integra Lifesciences (IART), currently trading at $15.06, will... Sign up to access price prediction.

About IART

LSE
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery.

  • Symbol

    IART

  • Market

    NASDAQ

  • Industry

    Medical - Devices

  • Market Cap

    1.2B

Similar Stocks

ALGN Align Technology
ALGN
$131.6
3.2%
5
IRTC iRhythm Technologies
IRTC
$179.8
0.7%
6
DXCM Dexcom
DXCM
$76.22
0.3%
5
BRKR Bruker
BRKR
$30.91
3.6%
5
TMCI Treace Medical Concepts
TMCI
$7.22
3%
5

IART Alternative Data

Web Traffic

Integra Lifesciences receives an estimated 130721 monthly visitors to integralife.com, which is down by -4.9% over the last month.

  • Web Traffic

    130721

  • Change from Previous Month

    4.9%

  • 3 Month Change

    35.6%

  • YoY Change

    35.6%

Twitter Followers

Integra Lifesciences has 2,051 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.1% over the last month.

  • Twitter Followers

    2051

  • Daily Change

    0%

  • 1 Month Change

    0.1%

  • 3 Month Change

    0%

  • YoY Change

    0%

Facebook Engagement

Integra Lifesciences has engaged 6 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    6

  • Daily Change

    20%

  • 1 Month Change

    200%

  • 3 Month Change

    40%

  • YoY Change

    40%

Instagram Followers

Integra Lifesciences has 1,956 Instagram Followers on its main Instagram account, up by 2% over the last month.

  • Instagram Followers

    1956

  • Daily Change

    0.1%

  • 1 Month Change

    2%

  • 3 Month Change

    2.9%

  • YoY Change

    2.9%

LinkedIn Followers

120,912 are following Integra Lifesciences on LinkedIn, up by 1.4% over the last month.

  • LinkedIn Followers

    120912

  • Daily Change

    0%

  • 1 Month Change

    1.4%

  • 3 Month Change

    3.9%

  • YoY Change

    3.9%

Job Postings

Integra Lifesciences currenly has an estimated 160 open job postings, up by 6% over the last month.

  • Job Postings

    160

  • Daily Change

    0%

  • 1 Month Change

    6%

  • 3 Month Change

    30.1%

  • YoY Change

    30.1%

LinkedIn Employees

According to LinkedIn, Integra Lifesciences has 3,887 employees, up by 0.2% over the last month.

  • LinkedIn Employees

    3887

  • Daily Change

    0.1%

  • 1 Month Change

    0.2%

  • 3 Month Change

    0.2%

  • YoY Change

    0.2%

Reddit Mentions

Integra Lifesciences has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Business Outlook

According to employee reviews, the business outlook among employees at Integra Lifesciences is 26 out of 100 (bearish), down by -3.7% over the last month.

  • Business Outlook

    26

  • Change from Previous Month

    3.7%

  • 3 Month Change

    7.1%

  • YoY Change

    7.1%

News Mentions

Integra Lifesciences was mentioned 1 times in the news yesterday.

  • News Mentions

    1

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

IART Financials

IART Key Metrics
  • Total Revenue

    $382.7M

  • Net Income

    -$25.3M

  • Earnings per Share

    -$0.33

  • Free cash flow

    -$11.3M

  • EBITDA

    -$15.5M

  • EBITDA Ratio

    -0.0404988

  • Total Assets

    $971.2M

IART 2-year Revenue & Income
IART 2-year Free Cash Flow

IART Technicals

IART SMA
IART RSI

FAQ

What's the current price of Integra Lifesciences (IART) Stock?
The price of an Integra Lifesciences (IART) share is $15.06.

What's the market cap of Integra Lifesciences?
The current market cap of Integra Lifesciences is 1.2B.

What are some stocks similar to Integra Lifesciences (IART) that investors often compare it to?
Integra Lifesciences (IART) is often compared to similar stocks such as Align Technology, iRhythm Technologies, Dexcom, Bruker and Treace Medical Concepts.

What is the forecast for Integra Lifesciences' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Integra Lifesciences' stock price to be around $14.63 in 2026. Starting from the current price of $15.06, this represents a 2.8% change in price, indicating a neutral outlook for the stock.

How to buy Integra Lifesciences (IART) Stock?
Integra Lifesciences stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Integra Lifesciences shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.